F605 in New York. Pick another state for the same tag.
Against expectation — 2025
New York cites F605 less often than its own record predicts
Versus expected share0.42×
0.42 times the national share — cited less often here than elsewhere.
Share of New York citations0.29%
Of every deficiency written in New York in 2025, this is the portion that was F605.
New York0.29%
National0.70%
Share of all citations that were F605.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New York surveyors wrote
F605 findings written in New York, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
G · Actual harm, isolatedApril 3, 2025
Based on record review and interviews during an abbreviated survey (NY00375411) the facility did not ensure that the resident was free from chemical restraints imposed for purposes of discipline or convenience, and not required to treat the resident's medical symptoms for one (1) out of three (3) residents (Resident #1) reviewed for restraints. Specifically, on 3/15/2025 the facility staff administered intramuscular anti-psychotic medication to Resident #1. Resident #1 was seen on a surveillance camera wandering on the unit and going in and out of other resident's rooms. …
D · No harm, potential for more than minimal, isolatedAugust 24, 2026
Based on observation, record review, and interviews conducted during a survey, the facility failed to ensure each resident's drug regimen was free from unnecessary psychotropic medications for one (Resident #1) of five residents reviewed. Specifically, Resident #1's medical record did not document consent for prescribed antipsychotic medication, mental health assessments, or evaluations. Findings include: The facility policy titled Psychotropic Medications revised 6/2025 documented, residents who are admitted from the community or transferred from a hospital and who are already receiving psychotropic medications will be evaluated for appropriateness and indications for use. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction